» Articles » PMID: 22208438

Modeling the Risk of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia in a High Risk Area in Iran

Overview
Journal Arch Iran Med
Specialty General Medicine
Date 2012 Jan 3
PMID 22208438
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Identifying people at higher risk of having squamous dysplasia, the precursor lesion for esophageal squamous cell carcinoma (ESCC), would allow targeted endoscopic screening.

Methods: We used multivariate logistic regression models to predict ESCC and dysplasia as outcomes. The ESCC model was based on data from the Golestan Case-Control Study (total n = 871; cases = 300), and the dysplasia model was based on data from a cohort of subjects from a gastroenterology clinic in Northeast Iran (total n = 724; cases = 26). In each of these analyses, we fit a model including all risk factors known in this region to be associated with ESCC. Individual risks were calculated using the linear combination of estimated regression coefficients and individual-specific values for covariates. We used cross-validation to determine the area under the curve (AUC) and to find the optimal cut points for each of the models.

Results: The model had an area under the curve of 0.77 (95% CI: 0.74-0.80) to predict ESCC with 74% sensitivity and 70.4% specificity for the optimum cut point. The area under the curve was 0.71 (95% CI: 0.64-0.79) for dysplasia diagnosis, and the classification table optimized at 61.5% sensitivity and 69.5% specificity. In this population, the positive and negative predictive values for diagnosis of dysplasia were 6.8% and 97.8%, respectively.

Conclusion: Our models were able to discriminate between ESCC cases and controls in about 77%, and between individuals with and without squamous dysplasia in about 70% of the cases. Using risk factors to predict individual risk of ESCC or squamous dysplasia still has limited application in clinical practice, but such models may be suitable for selecting high risk individuals in research studies, or increasing the pretest probability for other screening strategies.

Citing Articles

Design of risk prediction model for esophageal cancer based on machine learning approach.

Nopour R Heliyon. 2024; 10(2):e24797.

PMID: 38312629 PMC: 10835323. DOI: 10.1016/j.heliyon.2024.e24797.


Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma.

Moghaddam S, Forghanifard M Explor Target Antitumor Ther. 2023; 4(2):217-226.

PMID: 37205315 PMC: 10185436. DOI: 10.37349/etat.2023.00130.


Current Status and Future Prospects for Esophageal Cancer.

Sheikh M, Roshandel G, McCormack V, Malekzadeh R Cancers (Basel). 2023; 15(3).

PMID: 36765722 PMC: 9913274. DOI: 10.3390/cancers15030765.


Development and Validation of Esophageal Squamous Cell Carcinoma Risk Prediction Models Based on an Endoscopic Screening Program.

Han J, Guo X, Zhao L, Zhang H, Ma S, Li Y JAMA Netw Open. 2023; 6(1):e2253148.

PMID: 36701154 PMC: 9880791. DOI: 10.1001/jamanetworkopen.2022.53148.


Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population.

Liu M, Zhou R, Liu Z, Guo C, Xu R, Zhou F EClinicalMedicine. 2022; 47:101394.

PMID: 35480078 PMC: 9035729. DOI: 10.1016/j.eclinm.2022.101394.


References
1.
Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat S, Nouraie S . Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med. 2012; 15(4):196-200. DOI: 012154/AIM.004. View

2.
Vickers A . Prediction models in cancer care. CA Cancer J Clin. 2011; 61(5):315-26. PMC: 3189416. DOI: 10.3322/caac.20118. View

3.
Eslick G . Epidemiology of esophageal cancer. Gastroenterol Clin North Am. 2009; 38(1):17-25, vii. DOI: 10.1016/j.gtc.2009.01.008. View

4.
Aghcheli K, Marjani H, Nasrollahzadeh D, Islami F, Shakeri R, Sotoudeh M . Prognostic factors for esophageal squamous cell carcinoma--a population-based study in Golestan Province, Iran, a high incidence area. PLoS One. 2011; 6(7):e22152. PMC: 3141005. DOI: 10.1371/journal.pone.0022152. View

5.
Kamangar F, Malekzadeh R, Dawsey S, Saidi F . Esophageal cancer in Northeastern Iran: a review. Arch Iran Med. 2007; 10(1):70-82. DOI: 07101/AIM.0016. View